MarketPeel
Insider Trading Intelligence
Pricing
…
KM

Kevin Patrick Moran

VNDA
SVP, CFO & TREASURER · VANDA PHARMACEUTICALS INC. · CIK 0001806596
FILING MIX · LIFETIME42%/58%
BUYS
13
SELLS
18
TOTAL VALUE
$1.22M
COMPANIES
1
ACTIVE SINCE
Jul 2020
HOLDINGS NOW
411,380
AVG SELL PX
$7.93
TRADE KIND
SHOWING 31 / 31
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
17 backtested trades · 8 horizons · 5 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Kevin Patrick Moran, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d17+76.47%-4.24%-1.20%-3.04%+0.87%—
14d17+58.82%-3.84%-0.65%-3.20%-0.09%—
30d17+70.59%-3.48%+0.74%-4.22%-5.72%—
60d17+70.59%-8.56%-0.09%-8.47%-8.72%—
90d17+82.35%-10.43%+0.92%-10.68%-11.61%—
180d17(1 pending)+87.50%-15.14%+7.39%-22.53%-26.17%—
1y17(1 pending)+75.00%-19.98%+14.19%-34.16%-37.23%—
2y17(3 pending)+85.71%-25.45%+32.54%-57.99%-72.62%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
VNDA · 411,380 shares · as of Mar 2, 2026
0113,456226,911340,367453,822202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 13 buys / 18 sellsCOVERAGE · 23 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
VNDA
VANDA PHARMACEUTICALS INC.
SALE
SVP, CFO & Treasurer
42,442$8.27$350.8K411,380Mar 2, 2026Mar 4, 2026 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
125,000——453,822Feb 18, 2026Feb 19, 2026 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
SALE
SVP, CFO & Treasurer
26,941$4.76$128.2K328,822Mar 1, 2025Mar 4, 2025 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASE
SVP, CFO & Treasurer
2,000$4.39$8.8K355,763Feb 21, 2025Feb 24, 2025 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
125,000——353,763Feb 18, 2025Feb 20, 2025 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
SALE
SVP, CFO & Treasurer
2,251$5.92$13.3K228,763Jul 29, 2024Jul 29, 2024 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
SALE
SVP, CFO & Treasurer
8,902$4.20$37.4K231,014Mar 5, 2024Mar 6, 2024 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
SALE
SVP, CFO & Treasurer
5,798$4.48$26.0K239,916Mar 4, 2024Mar 6, 2024 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
125,000——245,714Feb 16, 2024Feb 21, 2024 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
SALE
SVP, CFO & Treasurer
1,800$6.31$11.3K120,714Jul 28, 2023Aug 1, 2023 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
SALE
SVP, CFO & Treasurer
412$6.30$2.6K122,514Jul 28, 2023Aug 1, 2023 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
SALE
SVP, CFO & Treasurer
16,000$6.29$100.7K122,926Jun 15, 2023Jun 20, 2023 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
SALE
SVP, CFO & Treasurer
5,968$6.28$37.5K138,926Mar 3, 2023Mar 6, 2023 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
SALE
SVP, CFO & Treasurer
7,966$6.26$49.8K144,894Mar 2, 2023Mar 6, 2023 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
77,500——77,500Feb 16, 2023Feb 21, 2023 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
32,700——152,860Feb 16, 2023Feb 21, 2023 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
SALE
SVP, CFO & Treasurer
4,792$10.61$50.8K120,160Dec 6, 2022Dec 7, 2022 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASE
SVP, CFO & Treasurer
7,500$3.12$23.4K124,952Dec 6, 2022Dec 7, 2022 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
SALE
SVP, CFO & Treasurer
7,500——0Dec 6, 2022Dec 7, 2022 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
SALE
SVP, CFO & Treasurer
2,239$10.97$24.6K117,452Jul 28, 2022Aug 1, 2022 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
SALE
SVP, CFO & Treasurer
8,832$11.28$99.6K119,691Mar 2, 2022Mar 2, 2022 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
SALE
SVP, CFO & Treasurer
3,473$11.19$38.9K128,523Mar 1, 2022Mar 2, 2022 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
32,700——131,996Feb 28, 2022Mar 2, 2022 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
77,500——77,500Feb 28, 2022Mar 2, 2022 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
SALE
SVP, CFO & Treasurer
2,130$19.24$41.0K99,296Jul 28, 2021Jul 30, 2021 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
SALE
SVP, CFO & Treasurer
6,044$18.23$110.2K101,426Mar 2, 2021Mar 3, 2021 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
SALE
SVP, CFO & Treasurer
3,327$18.57$61.8K107,470Mar 1, 2021Mar 3, 2021 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
32,700——110,797Feb 24, 2021Feb 26, 2021 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
77,500——77,500Feb 24, 2021Feb 26, 2021 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
17,344——78,097Jul 27, 2020Jul 29, 2020 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
90,000——90,000Jul 27, 2020Jul 29, 2020 ↗View →
Other insiders · VNDA
Loading peer insiders…
About this filer
CIK 0001806596
ROLE
SVP, CFO & Treasurer
PRIMARY
VNDA
COMPANIES
1
ACTIVE SINCE
Jul 2020
MARKETPEEL · /INSIDER/0001806596DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback